Sharp, a global provider of pharmaceutical packaging and contract manufacturing services, has announced a $20 million investment to expand its production capabilities in drug delivery devices. The project involves the installation of new automated assembly lines for autoinjectors and prefilled pen systems at the company’s facility in Allentown (Pennsylvania), one of Sharp’s key hubs serving the North American market.
The investment comes in response to the rising demand for combination products, which integrate drug formulation and device functionality to enable safe, precise, and user-friendly self-administration. Autoinjectors and pen devices have become central to the evolution of pharmaceutical packaging, supporting the shift from hospital-based treatment to home care while enhancing patient adherence and convenience.
The new lines feature advanced assembly and inspection systems designed to increase production capacity, improve efficiency, and ensure full compliance with FDA and GMP standards. Automation reduces contamination risks, strengthens traceability, and allows for greater flexibility in batch customization, an increasingly critical factor for pharmaceutical companies seeking agile, high-quality manufacturing partners.
Beyond the technical scope, Sharp’s expansion reflects a broader trend shaping the pharmaceutical packaging industry: the convergence of packaging and medical device design. As biologics and biosimilars continue to grow, the sector is moving towards functional and patient-centric packaging, capable of combining safety, ergonomics, and sustainability in a single solution.
The autoinjector and pen market is projected to expand significantly in the coming years, driven by innovation in reusable and recyclable components and by regulatory encouragement for more sustainable device design. With this $20 million investment, Sharp strengthens its global leadership in high-technology pharma packaging, positioning automation, quality, and innovation at the core of its strategy for the future of drug delivery systems.
Image Credits: Sharp
